Profound Medical (PROF) Insider Trading & Ownership $5.80 +0.10 (+1.82%) As of 11:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Profound Medical (NASDAQ:PROF) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.52%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$100.20KNumber OfInsiders Selling(Last 12 Months)0 Get PROF Insider Trade Alerts Want to know when executives and insiders are buying or selling Profound Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PROF Insider Buying and Selling by Quarter Profound Medical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/16/2025Arun Swarup MenawatCEOBuy12,027$4.73$56,887.71 5/15/2025Arun Swarup MenawatCEOBuy10,003$4.33$43,312.99 (Data available from 1/1/2013 forward) PROF Insider Trading Activity - Frequently Asked Questions Who is on Profound Medical's Insider Roster? The list of insiders at Profound Medical includes Arun Swarup Menawat. Learn more on insiders at PROF. What percentage of Profound Medical stock is owned by insiders? 1.52% of Profound Medical stock is owned by insiders. Learn more on PROF's insider holdings. Which Profound Medical insiders have been buying company stock? The following insider purchased PROF shares in the last 24 months: Arun Swarup Menawat ($100,200.70). How much insider buying is happening at Profound Medical? Insiders have purchased a total of 22,030 PROF shares in the last 24 months for a total of $100,200.70 bought. Profound Medical Key ExecutivesDr. Arun Swarup Menawat MBA (Age 69)Ph.D., Chairman of the Board & CEO Compensation: $435.87kMr. Rashed Dewan (Age 56)Chief Financial Officer Compensation: $215.18kDr. Mathieu Burtnyk (Age 42)Chief Operating Officer Compensation: $215.18kMr. Hartmut Warnken (Age 51)Chief Commercial Officer of Outside US Compensation: $226.17kMs. Abbey Goodman (Age 41)Chief Commercial Officer of US Compensation: $374.35kMr. Stephen KilmerInvestor RelationsMr. Jacques F. Cornet (Age 68)Senior VP & Product Leader Sonalleve Mr. Matthew Sobczyk C.A.CPA, Assistant Corporate ControllerMr. Levant TinazSoftware Developer More Insider Trading Tools from MarketBeat Related Companies CeriBell Insider Ownership Embecta Insider Ownership Beta Bionics Insider Ownership AVANOS MEDICAL Insider Ownership Bioventus Insider Ownership OrthoPediatrics Insider Ownership RxSight Insider Ownership AxoGen Insider Ownership Butterfly Network Insider Ownership Semler Scientific Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:PROF) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROF Stock Alerts